The latest market intelligence report, titled ‘Global Drug Screening Market’, is intended to provide the target audience with the necessary information about the global Drug Screening industry. The report comprises a detailed analysis of the vital elements of the Drug Screening market, including key drivers, constraints, opportunities, limitations, threats, and micro- and macro-economic factors. The report carefully investigates the present market scenario and the fundamental growth prospects. The report entails an organized database of the Drug Screening market dynamics that helps market analysts estimate the global market growth rate over the projected timeline.

Get a sample of the report @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=162987773

The global Drug Screening Market is expected to reach USD 11.6 Billion by 2026, according to a new report by MarketsandMarkets. The rising drug & alcohol consumption, the enforcement of stringent laws mandating drug and alcohol testing, government funding in major markets, and regulatory approvals and product and service launches are the major factors driving the growth of this market.

COVID-19 has resulted in significant disruptions to businesses and economic activities globally and is expected to have a short-term negative impact on the drug screening market due to limited or non-availability of medical facilities/treatment centers, harm reduction service providers, and the fear of infection transmission. To reduce the strain on the healthcare system and decrease disease transmission, various governments worldwide provided guidelines to postpone or delay non-essential medical and surgical procedures.

Market Dynamics:

The report offers insightful information about the market dynamics of the Drug Screening market. It offers SWOT analysis, PESTEL analysis, and Porter’s Five Forces analysis to present a better understanding of the Drug Screening market, competitive landscape, factors affecting it, and to predict the growth of the industry. It also offers the impact of various market factors along with the effects of the regulatory framework on the growth of the Drug Screening market.

Key companies profiled in the report include:

LabCorp (US), Quest Diagnostics (US), Abbott Laboratories (US), OraSure Technologies (US), Alfa Scientific Designs (US), Thermo Fisher Scientific (US), Drägerwerk (Germany), LifeLoc (US), MPD Inc. (US), Omega Laboratories (US)

Request for Bundle Reports @ https://www.marketsandmarkets.com/RequestBundleReport.asp?id=162987773

The study categorizes the Drug screening market into the following segments and subsegments:

By Product and Service

  • Drug Screening Product
  • Analytical Instruments
  • Rapid Testing Devices
  • Oral Fluid Testing Devices
  • Consumables
  • Drug Screening Service

By  Sample Type

  • Urine Samples
  • Breath Samples
  • Oral Fluid Samples
  • Hair Samples
  • Other Samples

By End User

  • Drug Testing Laboratories
  • Workplaces
  • Criminal Justice and Law Enforcement Agencies
  • Hospitals
  • Drug Treatment Centers
  • Individual Users
  • Pain Management Centers
  • Schools and Colleges

By Region

  • North America
  • Europe
  • Asia Pacific
  • Rest of the World 

ToC of the report:

Chapter 1: Market overview and scope

Chapter 2: Market outlook

Chapter 3: Impact analysis of COVID-19 pandemic

Chapter 4: Competitive Landscape

Chapter 5: Drivers, Constraints, Opportunities, Limitations

Chapter 6: Key manufacturers of the industry

Chapter 7: Regional analysis

Chapter 8: Market segmentation based on type & applications

Chapter 9: Current and Future Trends

Request customization of the report @ https://www.marketsandmarkets.com/Market-Reports/drug-alcohol-screening-market-162987773.html

Thank you for reading our report. Please get in touch with us for further queries about the report and our team will assist you according to your needs.